Amgen To Present At The 24th Annual Piper Jaffray Healthcare Conference

   Amgen To Present At The 24th Annual Piper Jaffray Healthcare Conference

PR Newswire

THOUSAND OAKS, Calif., Nov. 20, 2012

THOUSAND OAKS, Calif., Nov. 20, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will
present at the 24^th Annual Piper Jaffray Healthcare Conference on Wednesday,
Nov. 28, 2012, at the New York Palace hotel in New York City, beginning at
11:30 a.m. Eastern Standard Time. Arvind Sood, vice president of Investor
Relations at Amgen, will present. Live audio of the presentation can be
accessed from the Events Calendar on Amgen's website, www.amgen.com, under
Investors.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first
companies to realize the new science's promise by bringing safe, effective
medicines from lab to manufacturing plant to patient. Amgen therapeutics have
changed the practice of medicine, helping millions of people around the world
in the fight against cancer, kidney disease, rheumatoid arthritis, bone
disease and other serious illnesses. With a deep and broad pipeline of
potential new medicines, Amgen remains committed to advancing science to
dramatically improve people's lives. To learn more about our pioneering
science and vital medicines, visit www.amgen.com. Follow us on
www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Ashleigh Koss, 805-313-6151 (media)
Eric Hyllengren, 805-447-1060 (investors)

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

SOURCE Amgen

Website: http://www.amgen.com
 
Press spacebar to pause and continue. Press esc to stop.